Digoxin and xamoterol in patients with moderate chronic heart failure. A double-blind, randomized, controlled study

Cardiovascular Drugs and Therapy
E V SorensenO Faergeman

Abstract

Xamoterol is a partial beta 1 adrenoceptor agonist with positive inotropic properties. Treatment with xamoterol and digoxin was compared in 19 patients with cardiac failure (NYHA class II-III). The study consisted of a short-term and a long-term phase. The former was a randomized, double-blind, crossover study with 6-week treatment periods. In the 15 patients who completed this phase, there was no significant difference between exercise duration on digoxin and on xamoterol. Exercise duration increased on digoxin by 27% and on xamoterol by 17% relative to baseline. Comparing digoxin and xamoterol, maximum exercise heart rate (p less than 0.001), blood pressure (p less than 0.01), and the pressure-rate product during maximum exercise were significantly lower on xamoterol treatment. The systolic time interval was shorter on digoxin than on xamoterol (p less than 0.001). No changes occurred in the echocardiographic parameters. After the short-term study, 13 patients were followed 3-6 months on the drug to which they had responded best (digoxin 7, xamoterol 6). The results of the short-term study were maintained during this period. In conclusion, we found that xamoterol may be an alternative to digoxin in patients with mild to moder...Continue Reading

References

Mar 17, 1979·Lancet·G D Johnston, D G McDevitt
Oct 1, 1976·British Heart Journal·M T UptonD J Brown
Apr 1, 1971·Circulation·J F PomboR O Russell
Feb 1, 1968·Circulation·A M WeisslerC D Schoenfeld
Oct 1, 1982·British Journal of Pharmacology·A Nuttall, H M Snow
Nov 1, 1982·Progress in Cardiovascular Diseases·K ChatterjeeW W Parmley
Dec 18, 1980·The New England Journal of Medicine·S B ArnoldK Chatterjee
Mar 25, 1982·The New England Journal of Medicine·D C LeeE Haber

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.